tirzepatide and vision issues GLP-1 Medications Your Vision: What You Should Know Zepbound and Vision Loss: 20

We chose drugs that targeted key immunomodulatory pathways relevant to the pathogenesis of TB meningitis (aspirin, montelukast, bestatin, thalidomide, pomalidomide, navitoclax) 19,20,22,23,24,25 , showing promise in pulmonary TB (imatinib, roflumilast) 26,27,28 , or those being developed to target neuroinflammation for non-infectious indications (dabrafenib, palacaparib, semaglutide) 29,30,31

Sounds helpful, right

Within the GLP-1 sequences, the alanine at position 2 is substituted with a glycine residue to confer protection against DPP-IV

Wegovy, a higher-dose formulation of the same active ingredient, received FDA approval in 2021 explicitly for chronic weight management in adults with obesity or overweight with at least one weight-related health condition

The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis (Bays et al., NEJM 2025) reported 28.7% mean weight loss at 68 weeks at the 12 mg dose, plus a 75.8% reduction in WOMAC knee pain scores

No foods or beverages are completely off-limits